CLINICAL RESEARCH
A relationship between endoscopic findings
and diabetic regulation, and complications in patients with diabetes mellitus
More details
Hide details
1
Department of Internal Medicine, Van Education and Research Hospital, Van, Turkey
Submission date: 2020-07-21
Final revision date: 2020-07-29
Acceptance date: 2020-07-29
Publication date: 2020-11-18
Arch Med Sci Civil Dis 2020;5(1):53-57
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Diabetes mellitus (DM) is the most common endocrine disease. Increasing with a rapid acceleration, DM affects the society both financially and socially with its possible complications. Dyspeptic complaints occur in approximately 40% of DM patients. Dyspepsia in DM is a difficult condition to treat and requires patients’ frequent hospital visits. We aimed to examine a relationship between diabetic regulation and diabetic complications as well as endoscopic findings in patients with DM and dyspeptic complaints.
Material and methods:
Patients with a DM diagnosis from internal diseases outpatient clinic of our hospital who were followed-up between January 2019 and June 2020, and who underwent endoscopy for the upper gastrointestinal system were included. Diagnosis of DM was made according to the American Diabetes Association (ADA) criteria. Diabetic complications were questioned. A relationship between endoscopic and histopathological findings, glycated hemoglobin (HbA1c) level, and complications was investigated.
Results:
A total of 105 patients, 61 (58%) females, were included into the study. In a comparison between the groups, there was no statistically significant difference between glycemic regulation and endoscopic findings and the presence of HP. Comparing diabetic complications, no significant difference was observed in patients with complications from the endoscopic findings, except for pangastritis. The presence of HP was similar in both groups.
Conclusions:
It can be said that endoscopic findings and presence of HP are not closely related to glycemic control and complications in diabetic patients. However, these results should be supported by larger, multi-center, prospective studies.
REFERENCES (23)
1.
Kayar Y, Ilhan A, Kayar NB, et al. Relationship between the poor glycemic control and risk factors, life style and complications. Biomed Res 2017; 28: 23-5.
2.
Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014; 103: 137-49.
3.
Kayar Y, Pamukcu O, Eroglu H, et al. Relationship between Helicobacter pylori infections in diabetic patients and inflammations, metabolic syndrome, and complications. Int J Chronic Dis 2015; 2015: 290128.
4.
Kayar Y, Agin M. The relationship between demographic and anthropometric characteristics and diabetic complications and number of hospitalizations in hospitalized diabetic patients. Arch Med Sci Civil Dis 2019; 4: 7-15.
5.
Ma CC, Duan CC, Huang RC, Tang HQ. Association of circulating cystatin C levels with type 2 diabetes mellitus: a systematic review and meta-analysis. Arch Med Sci 2020; 16: 648-56.
6.
Menzin J, Langley-Hawthor C, Friedman M, Boulanger L, Cavanaugh R. Potential short-term economic benefits of improved glycemic control: a managed care perspective. Diabetes Care 2001; 24: 51-5.
7.
Menzin J, Korn JR, Cohen J, et al. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus. J Manag Care Pharm 2010; 16: 264-75.
8.
Bharucha AE, Kudva YC, Prichard DO. Diabetic gastroparesis. Endocr Rev 2019; 40: 1318-52.
9.
Koch CA, Uwaifo GI. Are gastrointestinal symptoms related to diabetes mellitus and glycemic control? Eur J Gastroenterol Hepatol 2008; 20: 822-5.
10.
American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2015; 38: 8-67.
11.
Satman I, Imamoğlu S, Yılmaz C, Akalın S ve Diabetes Mellitus Çalışma ve Eğitim Grubu. TEMD Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu, 5. Baskı. Bayt Matbaacılık, Ankara 2011.
12.
The TURDEP Group. Population-Based Study of Diabetes and Risk Characteristics in Turkey. Diabetes Care 2002; 25: 1551-6.
13.
The TURDEP Group. Population-Based Study of Diabetes and Risk Characteristics in Turkey, Istanbul, 2010.
14.
Zhaolan L, Chaowei F, Weibing W, Biao X. Prevalence of chronic complications of type 2 diabetes mellitus in outpatients – a cross-sectional hospital based survey in urban China. Health and Quality of Life Outcomes 2010; 8: 62.
15.
Rhee SY, Chon S, Kwon MK, et al. Prevalence of chronic complications in Korean patients with type 2 diabetes mellitus based on the Korean National Diabetes Program. Diabetes Metabol J 2011; 35: 504-12.
16.
Standards of Medical Care in diabetes – 2020. Diabetes Care 2020; 43 (Suppl. 1): 1-2.
17.
American Diabetes Association Professional Practice Committee. American Diabetes Association clinical practice recommendations. Diabetes Care January 2013; 36 (Suppl 1): 1-110.
18.
International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-34.
19.
Oner RI, Karincaoglu M. Correlation of dyspeptic symptoms and endoscopic findings in diabetic patient. Med Sci Discov 2018; 5: 130-6.
20.
Faria M, Pavin EJ, Parisi MCP, Nagasako CK, Mesquita MA. Dyspeptic symptoms in patients with type 1 diabetes: endoscopic findings, Helicobacter pylori infection, and associations with metabolic control, mood disorders and nutritional factors. Arch Endocrinol Metab 2015; 59: 2.
21.
Tseng PH, Lee YC, Chiu HM, et al. Association of diabetes and HbA1c levels with gastrointestinal manifestations. Diabetes Care 2012; 35: 1053-60.
22.
Anastasios R, Goritsas C, Papamihail C, et al. Helicobacter pylori infection in diabetic patients: prevalence and endoscopic findings. Eur J Intern Med 2002; 13: 376-9.
23.
Vasihnav BT, Shaikh SR, Bamanikar AA, et al. Diagnostic upper, gastrointestinal endoscopy and prevalence of Helicobacter pylori infection in dispeptic type 2 diabetes mellitus. J Dig Endosc 2018; 9: 53-60.